Information
- News
News21 Feb 2025Innovation in Poland: Łukasiewicz Analytical Report
Expenditures on research and development (R&D) in Poland doubled between 2010 and 2022. However, this increase has not been matched by a proportional improvement in the level of innovation. Poland's economy remains significantly less innovative than the European Union average. Enhancing innovation is essential for successfully closing the development gap with the rest of Europe. - News
News16 Jan 2025Strategic partnership for defence and innovation
Letter of intent between Łukasiewicz Centre, Łukasiewicz - Institute of Ceramics and Building Materials, Polski Holding Rozwoju S.A. (PHR), and Zakład Budowy Maszyn "ZREMB - Chojnice" S.A. (ZREMB) was signed on 15 January 2025 in Warsaw. This document paves the way for cooperation concerning joint technology development projects in the area of defence and national security, which constitutes one of the key strategic directions set out in the new strategy of the Łukasiewicz Research Network. - News
News16 Jan 2025Productoskop will make it easier to combat dual quality of products
If the composition of the same washing powder sold in Poland and Germany is different, we are dealing with so-called dual quality. Although it is an unlawful practice, exterminating it constitutes a challenge. The Produktoskop, a tool developed by researchers from the Łukasiewicz - Poznań Institute of Technology and the Poznań University of Technology, will be helpful in efforts to protect consumer rights. - News
News14 Jan 2025Łukasiewicz researcher with a publication in "Nature"
Dr Marek Wagner, head of the Innate Immunity Research Group at Łukasiewicz - PORT, has achieved something that does not happen very often in Polish (and not only) science, but is the dream of every researcher. He has just published an article in "Nature", one of the most prestigious scientific journals in the world. In it, he described, among other things, the results of his research on ILC2 immune cells. - News
News09 Jan 2025Polish APIs represent a health opportunity for millions of patients each year
Every year, 2.5 million patients can recover thanks to Polish researchers. Łukasiewicz - The Institute of Industrial Chemistry in Warsaw develops and produces active substances (APIs) that become the "heart" of medicines that restore the health of patients worldwide. In 2024 alone, the Institute produced 253,297,450 doses. - News
News07 Jan 2025Łukasiewicz Research Network implements its first-ever development strategy
Defence and security, chemistry for industry, energy transition and the circular economy - these are the four key directions on which the research and pro-innovation activities of the Łukasiewicz Research Network will focus starting in 2025. The new development strategy was prepared by the Łukasiewicz Centre in cooperation with 22 Network Institutes and external experts. - News
News19 Dec 2024Innovation, passion, and international cooperation - a visit by the Joint Research Centre at Łukasiewicz
The joint implementation of research projects constitutes one of the objectives of the visit of Joint Research Centre representatives to the Łukasiewicz institutes. Experts from the Brussels-based organisation, which is the research and analysis base of the European Commission, visited the Łukasiewicz Research Network for the second time. This time, they met with researchers from Łukasiewicz - PIAP, Łukasiewicz - PIMOT, Łukasiewicz - ILOT, and Łukasiewicz - ITECH. - News
News16 Dec 2024New technologies for Poland's security: cooperation between the Łukasiewicz Research Network and the Military Counterintelligence Service
Research concerning innovation in the national security and defence sector as well as the implementation of scientific results for technological security - this is the aim of the cooperation between the Łukasiewicz Research Network and the Military Counterintelligence Service. - News
News11 Dec 2024A Polish "game changer" in the treatment of multiple sclerosis
Soon multiple sclerosis patients will have access to cheaper and more effective drugs. The cladribine pill technology developed in Poland will bring a real breakthrough to the market, increasing access to effective treatment. - Events
